Differentiated Thyroid Cancer (DTC), Robotic Assistance
Conditions
Brief summary
The goal of this observational study is to learn the efficacy, cosmetic effectiveness and safety of robotic modified radical neck dissection in well-selected cases, through direct comparison with conventional open surgery in low-risk papillary thyroid carcinoma with lateral cervical lymph node metastasis. The main questions it aims to answer are: Does robotic neck dissection provide tumor clearance equivalent to that of the conventional open approach? How does the postoperative complication rate of the robotic technique compare with open surgery? Are patients satisfied with the cosmetic appearance of the wound following robotic neck dissection? Researchers will compare robotic surgery with conventional open surgery to see if it has the same efficacy, cosmetic effectiveness and safety. Participants' postoperative recovery will be followed up, and they will provide pain scores and rate their cosmetic satisfaction with the wound.
Interventions
None listed
Sponsors
Ruijin Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* (1) PTC with lateral LN metastasis confirmed by fine needle aspiration (FNA) biopsy; * (2) maximum tumor size \< 3 cm; * (3) without extrathyroidal extension; * (4) metastatic LNs in unilateral levels II, III, IV and/or V; * (5) number of suspicious metastatic LNs based on preoperative ultrasonography \< 5; * (6) maximum metastatic LN diameter \< 3 cm.
Exclusion criteria
* (1) metastatic LNs in level I or VII; * (2) metastatic LNs fused with each other or fixed in the neck or extra-nodal extension; * (3) history of neck surgery or radiation therapy; * (4) extranodal extension; * (5) the presence of TERT mutation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of retrieved Lymph nodes | From enrollment to the end of surgical procedure | — |
| postoperative complications | From enrollment to the end of treatment at 1 year | Vocal cord paralysis; hypocalcemia; spinal accessory nerve injury; chyle leakage |
Countries
China
Outcome results
None listed